Status:
COMPLETED
To Evaluate the Bioavailability of a Tablet of AZD1656
Lead Sponsor:
AstraZeneca
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
20-65 years
Phase:
PHASE1
Brief Summary
To evaluate the bioavailability of a tablet of AZD1656.
Eligibility Criteria
Inclusion
- Male or female, type I diabetes patients, female with non child-bearing potential.
- Treated with insulin for more than 3 years. Well controlled HbA1c.
- Have a body mass index (BMI) ≥19 and ≤35
Exclusion
- Clinically significant illness except type I diabetes, or clinically relevant trauma, as judged by the investigator, within 2 weeks before the first administration of the investigational product
- Daily use of nicotine containing substances.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00817505
Start Date
December 1 2008
End Date
September 1 2009
Last Update
November 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research site
San Antonio, Texas, United States